4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001181431-06-037253
Options or other derivatives
- Chief Financial Officer acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| MURPHY JAMES B Chief Financial Officer | 2006-06-14 | Grant or award · Option to Purchase Common Stock | +25,000 | 25,000 | D: show line 1 in the form |
Loading xslF345X02/rrd121523.xml…